Cart
sales@molnova.com
Isomagnolone
CAS No. 155709-41-4
Isomagnolone( —— )
Catalog No. M23672 CAS No. 155709-41-4
Isomagnolone is a natural product isolated from Illicium burmanicum and has anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 392 | In Stock |
|
| 5MG | 382 | In Stock |
|
| 10MG | 543 | In Stock |
|
| 25MG | 809 | In Stock |
|
| 50MG | 1070 | In Stock |
|
| 100MG | 1442 | In Stock |
|
| 200MG | 1841 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIsomagnolone
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsomagnolone is a natural product isolated from Illicium burmanicum and has anti-inflammatory activity.
-
DescriptionIsomagnolone is a natural product isolated from Illicium burmanicum and has anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number155709-41-4
-
Formula Weight282.3
-
Molecular FormulaC18H18O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC=CCC1=CC=C(O)C(OC2=CC=C(C(CC)=O)C=C2)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neolignans from the fruits of Magnolia obovata and their inhibition effect on NO production in LPS-induced RAW 264.7 cells.Planta Med. 2013 Sep;79(14):1335-40.
molnova catalog
related products
-
Amyloid Bri Protein ...
Amyloid Bri Protein Precursor277 (89-106)
-
Neuropeptide Y (3-36...
Neuropeptide Y (3-36) (porcine) is an agonist of neuropeptide Y (NPY) receptor subtype Y2, and stimulates feeding in rats. Neuropeptide Y (3-36) (porcine) is a highly Y2 selective ligand compared with nselective Y1/Y2 receptor ligand, Neuropeptide Y 1-36.
-
diaminohydroxypropan...
Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others
